Greystone Flat on Latest Financials
Greystone Housing Impact Investors LP (NYSE: GHI) saw its stock price barely move on Thursday, on releasing financial results for the three months ended June 30, 2025. Net loss was reported at $7.1 million or $0.35 per Beneficial Unit Certificate, basic and dilutedCash Available for Distribution (CAD) $5.7 million or $0.25 per BUC. Total assets of $1.48 billionTotal Mortgage Revenue Bond and Governmental Issuer Loan investments of $1.13 billion. The difference between reported net income and CAD is primarily due to the treatment of provisions for credit losses and unrealized losses on the Partnership’s interest rate derivative positions. A reconciliation of net income to CAD is included below under “Disclosure Regarding Non-GAAP Measures - Cash Available for Distribution.”In June 2025, the Partnership announced that the Board of Managers of Greystone AF Manager LLC declared a regular quarterly distribution to the Partnership's BUC holders of $0.30 per BUC. The distribution was paid on July 31, 2025, to BUC holders of record as of the close of trading on June 30, 2025. Said CEO Kenneth C. Rogozinski. “In the second quarter, we extended the maturity date for both of our corporate credit lines and increased our total borrowing capacity by $30 million. In July, we received an additional capital commitment of approximately $60 million for the BlackRock construction lending joint venture from a second institutional investor. Both of these developments make us well positioned to deploy capital into new affordable housing investment opportunities.”GHI shares dipped a penny to $10.70.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


